POST-THROMBOTIC SYNDROME
Clinical trials for POST-THROMBOTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-THROMBOTIC SYNDROME trials appear
Sign up with your email to follow new studies for POST-THROMBOTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old drug, new hope: colchicine trial aims to stop Post-Clot leg damage
Disease control Not yet recruitingThis study tests whether adding colchicine, an anti-inflammatory pill, to standard blood thinners can prevent long-term vein damage (post-thrombotic syndrome) in people with a first-time deep vein clot in the leg. About 940 adults will receive either colchicine or a placebo for o…
Matched conditions: POST-THROMBOTIC SYNDROME
Phase: PHASE3 • Sponsor: Azienda Sanitaria Locale ASL 6, Livorno • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Hidden danger: clots linger after catheters removed in ICU
Knowledge-focused Not yet recruitingThis observational study will follow 300 intensive care unit patients to see how often blood clots caused by central venous catheters remain in the vein after the catheter is taken out. Researchers want to identify risk factors and track whether these clots dissolve or lead to se…
Matched conditions: POST-THROMBOTIC SYNDROME
Sponsor: Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s. • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC